Papers
2
Total Citations
9
H-Index
2
About
Chunguang Guo is a surgical oncologist whose research focuses on improving outcomes for patients with hepatopancreatobiliary malignancies, particularly ampullary carcinoma and bile duct injury (BDI). His work centers on developing novel prognostic tools and refining surgical quality metrics. Guo’s major contributions include the creation of a preoperative prognostic score combining total bilirubin-albumin and fibrinogen-albumin ratios to predict survival in ampullary adenocarcinoma, offering a practical, non-invasive risk stratification method. He has also pioneered the application of “textbook outcomes”—a composite measure of ideal postoperative results—to ampullary carcinoma patients undergoing pancreaticoduodenectomy, providing a benchmark for surgical quality. His 2023 study on textbook outcomes has garnered 6 citations, while his prognostic score paper has received 3 citations, reflecting growing interest in his work. Notably, Guo addresses the persistent challenge of postcholecystectomy BDI, a devastating complication that, despite declining incidence, remains a significant burden on patients and healthcare systems. His research bridges the gap between surgical technique and patient-centered outcomes, offering actionable insights for clinicians. Guo’s work is essential reading for surgeons and researchers seeking to optimize care for complex biliary and pancreatic diseases.
Research Focus
Key Achievements
Top Papers
- 1
- 2